Gene Therapy
Gene therapy delivers a working copy of a gene, or a correction to a faulty one, usually once and for life. Manufacturing the delivery vector is often harder than designing the therapy.
131 stocks
| # | Name | Holding | Trade Value |
Theme Stocks |
% of Portfolio | Status | |
|---|---|---|---|---|---|---|---|
| 26 |
JP Morgan Chase
New York
| $361M | +$1.8M | 16 | 0.09% | Increased |
|
| 27 |
BlackRock Advisors
Wilmington,
Delaware
| $354M | +$81.9M | 26 | 0.37% | Increased |
|
| 28 |
Capital World Investors
Los Angeles,
California
| $348M | +$12.9M | 4 | 0.09% | Increased |
|
| 29 |
Columbia Wanger Asset Management
Chicago,
Illinois
| $346M | +$12.3M | 2 | 2.23% | Increased |
|
| 30 |
Jennison Associates
New York
| $336M | -$7.31M | 11 | 0.31% | Reduced |
|
| 31 |
Bank of New York Mellon
New York
| $330M | +$5.59M | 24 | 0.09% | Increased |
|
| 32 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
| $288M | +$30.2M | 2 | 20.71% | Increased |
|
| 33 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| $285M | -$2.2M | 21 | 0.34% | Reduced |
|
| 34 |
Ameriprise
Minneapolis,
Minnesota
| $277M | -$13.3M | 9 | 0.16% | Reduced |
|
| 35 |
Bank of America
Charlotte,
North Carolina
| $273M | +$14.6M | 27 | 0.09% | Increased |
|
| 36 |
UBS AM
Chicago,
Illinois
| $267M | +$10.3M | 12 | 0.26% | Increased |
|
| 37 |
Janus Henderson Investors US
Denver,
Colorado
| $266M | +$77M | 7 | 0.22% | Increased |
|
| 38 |
Goldman Sachs
New York
| $260M | +$36.4M | 21 | 0.08% | Increased |
|
| 39 |
Parnassus Investments
San Francisco,
California
| $260M | -$21.4M | 1 | 1.86% | Reduced |
|
| 40 |
Baupost Group
Boston,
Massachusetts
| $254M | +$2.13M | 1 | 4.23% | Increased |
|
| 41 |
VAM
Visium Asset Management
New York
| $251M | +$102M | 12 | 3.55% | Increased |
|
| 42 |
Renaissance Technologies
New York
| $244M | +$22.8M | 15 | 0.56% | Increased |
|
| 43 |
Lazard Asset Management
New York
| $238M | +$21.5M | 6 | 0.5% | Increased |
|
| 44 |
ClearBridge Investments
New York
| $237M | -$5.44M | 4 | 0.25% | Reduced |
|
| 45 |
EARNEST Partners
Atlanta,
Georgia
| $219M | +$5.96M | 1 | 1.91% | Increased |
|
| 46 |
First Trust Advisors
Wheaton,
Illinois
| $218M | +$57.7M | 4 | 0.57% | Increased |
|
| 47 |
Millennium Management
New York
| $214M | -$76.1M | 25 | 0.41% | Reduced |
|
| 48 |
OppenheimerFunds
New York
| $210M | -$9.19M | 6 | 0.24% | Reduced |
|
| 49 |
Mawer Investment Management
Calgary,
Alberta, Canada
| $210M | +$31.7M | 1 | 2.67% | Increased |
|
| 50 |
Lord, Abbett & Co
Jersey City,
New Jersey
| $210M | -$69.5M | 8 | 0.55% | Reduced |
|